PubMed:22825334 / 371-566
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T72 | 10-23 | CVCL_5552 | denotes | MCF10DCIS.com |
T73 | 15-19 | D002285 | denotes | DCIS |
T75 | 15-19 | D002285 | denotes | DCIS |
T77 | 20-23 | CHEBI:17905 | denotes | com |
T78 | 24-29 | D006801 | denotes | human |
T79 | 30-36 | UBERON:0000310 | denotes | breast |
T80 | 30-43 | D001943 | denotes | breast cancer |
T81 | 30-43 | D001943 | denotes | breast cancer |
T83 | 74-82 | Q17391 | denotes | Cullin-3 |
T84 | 74-82 | PR:000006048 | denotes | Cullin-3 |
T85 | 74-82 | Q09760 | denotes | Cullin-3 |
T86 | 74-82 | P53202 | denotes | Cullin-3 |
T87 | 74-82 | Q9JLV5 | denotes | Cullin-3 |
T88 | 74-82 | Q13618 | denotes | Cullin-3 |
T89 | 74-82 | Q54NZ5 | denotes | Cullin-3 |
T90 | 74-82 | B5DF89 | denotes | Cullin-3 |
T91 | 74-82 | A4IHP4 | denotes | Cullin-3 |
T94 | 140-164 | D002285 | denotes | ductal carcinoma in situ |
T95 | 140-164 | D002285 | denotes | ductal carcinoma in situ |
T101 | 166-170 | CVCL_5552 | denotes | DCIS |
T100 | 166-170 | D002285 | denotes | DCIS |
T102 | 166-170 | D002285 | denotes | DCIS |
T103 | 184-194 | D002277 | denotes | carcinomas |
T104 | 184-194 | D002277 | denotes | carcinomas |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_22825334_3_0 | 140-164 | expanded | denotes | ductal carcinoma in situ |
SS2_22825334_3_0 | 166-170 | abbr | denotes | DCIS |
AE1_22825334_3_0 | SS1_22825334_3_0 | SS2_22825334_3_0 | abbreviatedTo | ductal carcinoma in situ,DCIS |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-195 | DRI_Outcome | denotes | Using the MCF10DCIS.com human breast cancer xenograft model, we show that Cullin-3 is increasingly expressed during progression from comedo ductal carcinoma in situ (DCIS) to invasive carcinomas. |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-195 | DRI_Outcome | denotes | Using the MCF10DCIS.com human breast cancer xenograft model, we show that Cullin-3 is increasingly expressed during progression from comedo ductal carcinoma in situ (DCIS) to invasive carcinomas. |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 30-43 | HP_0003002 | denotes | breast cancer |
T4 | 30-43 | HP_0100013 | denotes | breast cancer |
T5 | 37-43 | HP_0002664 | denotes | cancer |